Status:
COMPLETED
Neuropeptides in the Humane Intra- og Extracerebral Circulation.
Lead Sponsor:
Danish Headache Center
Collaborating Sponsors:
Glostrup University Hospital, Copenhagen
Bispebjerg Hospital
Conditions:
Healthy
Migraine
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cy...
Detailed Description
The study is meant to give a better understanding of the basic mechanisms behind migraine, and a better understanding of the effects of sumatriptan on the trigemino vascular system. The endpoints are...
Eligibility Criteria
Inclusion
- healthy volunteers
- 18-50 years,
- 50-100 kg.
- Fertile women must use birth control.
Exclusion
- All primary types of headache
- Daily intake of medicine except birth control
- Pregnancy
- Hypertension
- Hypotension
- other chronic disease
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00399633
Start Date
January 1 2007
End Date
April 1 2007
Last Update
May 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Headache Center
Glostrup, Copenhagen, Copenhagen, Denmark, 2600